Classification
Compound class	Antibody
Approved drug?	Yes (source: FDA (2001), EMA (2001))

International Nonproprietary Names
INN number	INN
8005	alemtuzumab

Synonyms

campath 1H

Campath®

campath-1H

Lemtrada®

Database Links
Specialist databases
IMGT/mAb-DB	11
Other databases
PubChem SID	178103376
Search PubMed clinical trials	alemtuzumab
Search PubMed titles	alemtuzumab
Search PubMed titles/abstracts	alemtuzumab
Wikipedia	Alemtuzumab

Comments

CAMPATH-1 (CD52) antigen inhibitor. Functionally, alemtuzumab causes depletion and then recovery of the immune system. Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.